SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

MediXall Group, Inc. – ‘10-Q’ for 9/30/22 – ‘EX-101.SCH’

On:  Monday, 11/14/22, at 4:39pm ET   ·   For:  9/30/22   ·   Accession #:  1553350-22-902   ·   File #:  333-194337

Previous ‘10-Q’:  ‘10-Q’ on 8/23/22 for 6/30/22   ·   Latest ‘10-Q’:  This Filing

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/14/22  MediXall Group, Inc.              10-Q        9/30/22   47:2.8M                                   Edgar Filing LLC/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    628K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     17K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     14K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     14K 
11: R1          Cover                                               HTML     64K 
12: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    103K 
13: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     38K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     88K 
                (Unaudited)                                                      
15: R5          Consolidated Statements of Changes in               HTML     80K 
                Stockholders' Equity (Deficit) (Unaudited)                       
16: R6          Consolidated Statements of Changes in               HTML     17K 
                Stockholders' Equity (Deficit) (Unaudited)                       
                (Parenthetical)                                                  
17: R7          Condensed Consolidated Statements of Cash Flows     HTML     88K 
                (Unaudited)                                                      
18: R8          Organization and Nature of Operation                HTML     20K 
19: R9          Asset Acquisition                                   HTML     19K 
20: R10         Going Concern                                       HTML     21K 
21: R11         Summary of Significant Accounting Policies          HTML     69K 
22: R12         Right-to-use Intellectual Property                  HTML     30K 
23: R13         Preferred Stock                                     HTML     26K 
24: R14         Related Party Transactions                          HTML     34K 
25: R15         Senior Convertible Debentures and Warrants          HTML     31K 
26: R16         Summary of Significant Accounting Policies          HTML    102K 
                (Policies)                                                       
27: R17         Summary of Significant Accounting Policies          HTML     49K 
                (Tables)                                                         
28: R18         Right-to-use Intellectual Property (Tables)         HTML     30K 
29: R19         Related Party Transactions (Tables)                 HTML     26K 
30: R20         Senior Convertible Debentures and Warrants          HTML     25K 
                (Tables)                                                         
31: R21         Asset Acquisition (Details Narrative)               HTML     22K 
32: R22         Going Concern (Details Narrative)                   HTML     23K 
33: R23         Summary of Significant Accounting Policies          HTML     28K 
                (Schedule of Basic and Diluted EPS) (Details)                    
34: R24         Summary of Significant Accounting Policies          HTML     22K 
                (Schedule of potentially dilutive securities)                    
                (Details)                                                        
35: R25         Summary of Significant Accounting Policies          HTML     18K 
                (Details Narrative)                                              
36: R26         Right-to-use Intellectual Property (Schedule of     HTML     22K 
                Right-to-use Intellectual Property) (Details)                    
37: R27         Right-to-use Intellectual Property (Schedule of     HTML     30K 
                amortization expense for right-to-use intellectual               
                property) (Details)                                              
38: R28         Preferred Stock (Details Narrative)                 HTML     37K 
39: R29         Related Party Transactions (Details)                HTML     32K 
40: R30         Related Party Transactions (Details Narrative)      HTML     29K 
41: R31         Senior Convertible Debentures and Warrants          HTML     30K 
                (Details)                                                        
42: R32         Senior Convertible Debentures and Warrants          HTML     43K 
                (Details Narrative)                                              
45: XML         IDEA XML File -- Filing Summary                      XML     78K 
43: XML         XBRL Instance -- mdxl_10q_htm                        XML    646K 
44: EXCEL       IDEA Workbook of Financial Reports                  XLSX     71K 
 7: EX-101.CAL  XBRL Calculations -- mdxl-20220930_cal               XML    107K 
 8: EX-101.DEF  XBRL Definitions -- mdxl-20220930_def                XML    226K 
 9: EX-101.LAB  XBRL Labels -- mdxl-20220930_lab                     XML    485K 
10: EX-101.PRE  XBRL Presentations -- mdxl-20220930_pre              XML    398K 
 6: EX-101.SCH  XBRL Schema -- mdxl-20220930                         XSD     87K 
46: JSON        XBRL Instance as JSON Data -- MetaLinks              204±   287K 
47: ZIP         XBRL Zipped Folder -- 0001553350-22-000902-xbrl      Zip    130K

‘EX-101.SCH’   —   XBRL Schema — mdxl-20220930

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.16a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<!-- Field: Doc-Info; Name: Misc; Value: +qsps7xRiXgOn8uMY3pMOaSNWbP9z5V9mYkhsWt5bVmq7yos0v75QiOM42N2gdME -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:mdxl="http://medixall.com/20220930" elementFormDefault="qualified" targetNamespace="http://medixall.com/20220930">
<annotation>
<appinfo>
<link:roleType roleURI="http://medixall.com/role/Cover" id="Cover">
<link:definition> 00000001 - Document - Cover </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
<link:definition> 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
<link:definition> 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
<link:definition> 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficit" id="ConsolidatedStatementsOfChangesInStockholdersEquityDeficit">
<link:definition> 00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/ConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical" id="ConsolidatedStatementsOfChangesInStockholdersEquityDeficitParenthetical">
<link:definition> 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
<link:definition> 00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/OrganizationAndNatureOfOperation" id="OrganizationAndNatureOfOperation">
<link:definition> 00000008 - Disclosure - Organization and Nature of Operation </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/AssetAcquisition" id="AssetAcquisition">
<link:definition> 00000009 - Disclosure - Asset Acquisition </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/GoingConcern" id="GoingConcern">
<link:definition> 00000010 - Disclosure - Going Concern </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition> 00000011 - Disclosure - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/Right-to-useIntellectualProperty" id="Right-to-useIntellectualProperty">
<link:definition> 00000012 - Disclosure - Right-to-use Intellectual Property </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/PreferredStock" id="PreferredStock">
<link:definition> 00000013 - Disclosure - Preferred Stock </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition> 00000014 - Disclosure - Related Party Transactions </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/SeniorConvertibleDebenturesAndWarrants" id="SeniorConvertibleDebenturesAndWarrants">
<link:definition> 00000015 - Disclosure - Senior Convertible Debentures and Warrants </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 00000016 - Disclosure - Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
<link:definition> 00000017 - Disclosure - Summary of Significant Accounting Policies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/Right-to-useIntellectualPropertyTables" id="Right-to-useIntellectualPropertyTables">
<link:definition> 00000018 - Disclosure - Right-to-use Intellectual Property (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/RelatedPartyTransactionsTables" id="RelatedPartyTransactionsTables">
<link:definition> 00000019 - Disclosure - Related Party Transactions (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsTables" id="SeniorConvertibleDebenturesAndWarrantsTables">
<link:definition> 00000020 - Disclosure - Senior Convertible Debentures and Warrants (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/AssetAcquisitionDetailsNarrative" id="AssetAcquisitionDetailsNarrative">
<link:definition> 00000021 - Disclosure - Asset Acquisition (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/GoingConcernDetailsNarrative" id="GoingConcernDetailsNarrative">
<link:definition> 00000022 - Disclosure - Going Concern (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedEpsDetails" id="SummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedEpsDetails">
<link:definition> 00000023 - Disclosure - Summary of Significant Accounting Policies (Schedule of Basic and Diluted EPS) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesDetails" id="SummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesDetails">
<link:definition> 00000024 - Disclosure - Summary of Significant Accounting Policies (Schedule of potentially dilutive securities) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
<link:definition> 00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfRight-to-useIntellectualPropertyDetails" id="Right-to-useIntellectualPropertyScheduleOfRight-to-useIntellectualPropertyDetails">
<link:definition> 00000026 - Disclosure - Right-to-use Intellectual Property (Schedule of Right-to-use Intellectual Property) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails" id="Right-to-useIntellectualPropertyScheduleOfAmortizationExpenseForRight-to-useIntellectualPropertyDetails">
<link:definition> 00000027 - Disclosure - Right-to-use Intellectual Property (Schedule of amortization expense for right-to-use intellectual property) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/PreferredStockDetailsNarrative" id="PreferredStockDetailsNarrative">
<link:definition> 00000028 - Disclosure - Preferred Stock (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/RelatedPartyTransactionsDetails" id="RelatedPartyTransactionsDetails">
<link:definition> 00000029 - Disclosure - Related Party Transactions (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
<link:definition> 00000030 - Disclosure - Related Party Transactions (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetails" id="SeniorConvertibleDebenturesAndWarrantsDetails">
<link:definition> 00000031 - Disclosure - Senior Convertible Debentures and Warrants (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://medixall.com/role/SeniorConvertibleDebenturesAndWarrantsDetailsNarrative" id="SeniorConvertibleDebenturesAndWarrantsDetailsNarrative">
<link:definition> 00000032 - Disclosure - Senior Convertible Debentures and Warrants (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="mdxl-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="mdxl-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="mdxl-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="mdxl-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
<import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
<import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd"/>
<import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd"/>
<import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
<import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
<import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
<element id="mdxl_SeriesAVotingPreferredStockMember" name="SeriesAVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_SeriesBVotingPreferredStockMember" name="SeriesBVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_MediXallGroupIncMember" name="MediXallGroupIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_SeniorConvertibleDebenturesAndWarrantsMember" name="SeniorConvertibleDebenturesAndWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_TBGMember" name="TBGMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_R3AccountingLLCMember" name="R3AccountingLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_TBGHoldingsCorpMember" name="TBGHoldingsCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_TurnkeyMember" name="TurnkeyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_ThreeConvertibleLoanDebenturesMember" name="ThreeConvertibleLoanDebenturesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_ProfessionalFeesRelatedParty" name="ProfessionalFeesRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_ManagementFeeRelatedParty" name="ManagementFeeRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_RetirementOfCommonSharesIssuedForServicesUnaudited" name="RetirementOfCommonSharesIssuedForServicesUnaudited" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_RetirementOfCommonSharesIssuedForServicesShares" name="RetirementOfCommonSharesIssuedForServicesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_CommonStockIssuedInExchangeForRighttouseIntellectualProperty" name="CommonStockIssuedInExchangeForRighttouseIntellectualProperty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_CommonStockIssuedInExchangeForRighttouseIntellectualPropertyShares" name="CommonStockIssuedInExchangeForRighttouseIntellectualPropertyShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_FairValueOfWarrantsIssuedWithConvertibleDebentures" name="FairValueOfWarrantsIssuedWithConvertibleDebentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_ProceedsReceivedFromSaleOfPreferredStock" name="ProceedsReceivedFromSaleOfPreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_ProceedsReceivedFromSaleOfPreferredStockShares" name="ProceedsReceivedFromSaleOfPreferredStockShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_AmortizationOfDebentureDiscounts" name="AmortizationOfDebentureDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_GainFromForgivenessOfNotePayable" name="GainFromForgivenessOfNotePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_IncreaseDecreaseInPrepaidExpensesRelatedParty" name="IncreaseDecreaseInPrepaidExpensesRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_AmortizationOfRightofuseOperatingLeaseAsset" name="AmortizationOfRightofuseOperatingLeaseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_AmortizationOfRighttouseIntellectualProperty" name="AmortizationOfRighttouseIntellectualProperty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_IncreaseDecreaseAmortizationOfWebsiteAndDevelopment" name="IncreaseDecreaseAmortizationOfWebsiteAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_WebsiteAndDevelopmentCosts" name="WebsiteAndDevelopmentCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_IssuanceOfCommonStockInExchangeForRighttouseIntellectualProperty" name="IssuanceOfCommonStockInExchangeForRighttouseIntellectualProperty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_DiscountIssuedWithConvertibleDebentures" name="DiscountIssuedWithConvertibleDebentures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_DecreaseInNotePayableResultingFromGainOnForgivenessOfNotePayable" name="DecreaseInNotePayableResultingFromGainOnForgivenessOfNotePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_RightofuseLeaseAssetsObtainedInExchangeForOperatingLeaseLiabilities" name="RightofuseLeaseAssetsObtainedInExchangeForOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_RetirementOfCommonSharesIssuedForServices" name="RetirementOfCommonSharesIssuedForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_DisclosureAssetAcquisitionAbstract" name="DisclosureAssetAcquisitionAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_AssetAcquisitionDisclosureTextBlock" name="AssetAcquisitionDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_DisclosureSeniorConvertibleDebenturesAndWarrantsAbstract" name="DisclosureSeniorConvertibleDebenturesAndWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_SeniorConvertibleDebenturesAndWarrantsTextBlock" name="SeniorConvertibleDebenturesAndWarrantsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_SeniorConvertibleDebenturesAndWarrantsPolicyTextBlock" name="SeniorConvertibleDebenturesAndWarrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_RightsToUseIntellectualPropertyPolicyTextBlock" name="RightsToUseIntellectualPropertyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_ScheduleOfRightToUseIntellectualPropertyTableTextBlock" name="ScheduleOfRightToUseIntellectualPropertyTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_ScheduleOfAmortizationExpenseForTheRightToUseIntellectualPropertyTableTextBlock" name="ScheduleOfAmortizationExpenseForTheRightToUseIntellectualPropertyTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_IntellectualPropertyValue" name="IntellectualPropertyValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_AdditionalSharesIssued" name="AdditionalSharesIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_EarningsPerSharesBasicAndDilutedAbstract" name="EarningsPerSharesBasicAndDilutedAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_NumeratorAbstract" name="NumeratorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_LossAvailableToCommonStockholders" name="LossAvailableToCommonStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_DenominatorAbstract" name="DenominatorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_WeightedAverageNumberOfCommonSharesOutstanding" name="WeightedAverageNumberOfCommonSharesOutstanding" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_BasicAndDilutedLps" name="BasicAndDilutedLps" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_ConvertiblePreferredStockTotalSharesIssuedUponConversion" name="ConvertiblePreferredStockTotalSharesIssuedUponConversion" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="mdxl_SecuritiesPurchaseAgreementDescription" name="SecuritiesPurchaseAgreementDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
</schema>

↑Top
Filing Submission 0001553350-22-000902   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., Apr. 27, 11:06:46.1am ET